Tamarind Bio announced it raised $13.6 Million in an initial filing from an offering of $13.6 Million

Company

Location

About

Tamarind provides powerful web interfaces and APIs for the world’s leading protein design tools, enabling researchers and organizations to run models like AlphaFold/Chai-1, RFdiffusion, ProteinMPNN, and over 100 others at massive scale. With support for parallel processing of hundreds of thousands of inputs, Tamarind is trusted by top biopharma companies to accelerate tasks such as de novo binder design, antigen stabilization, binder affinity optimization, and antibody developability scoring — all through a seamless and scalable platform.